Six new studies from DaVita Clinical Research spotlight improved outcomes with GLP-1 use, advancements in treatments, transplant access and end-of-life care "Kidney Week isn't just a conference — it's ...
Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. Dr ...
ASN Kidney Week is the world’s premier nephrology meeting, bringing together thousands of kidney professionals from around the globe. Hosted by the American Society of Nephrology (ASN), this annual ...
Please provide your email address to receive an email when new articles are posted on . Disease remission is now achievable, and cure might be on the horizon, according to a speaker at ASN Kidney Week ...
Please provide your email address to receive an email when new articles are posted on . New therapies, like drugs for glomerular diseases and kidney replacement devices, offer potential for treating ...
Houston, TX (November 8, 2025) — It can be challenging to identify which patients with advanced chronic kidney disease (CKD) will most benefit from conservative care rather than initiating dialysis.
- Updated data from RUBY-3 trial of povetacicept accepted for late breaking oral presentation; inaxaplin study design and APOL1-mediated kidney disease related data accepted for poster presentation - ...
Interim results from a phase III trial were presented at the Kidney Week meeting ...
Houston, TX (November 8, 2025) — A 5-year study revealed a stability of globalacute kidney injury (AKI)–related mortality rates with differing patterns that indicate a rising concentration of ...
Hear about the opportunities and resources offered by our National Resource Centers at ASN Kidney Week. Ask questions, discuss research, and learn more from NRC representatives at the OKRA booth. If ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results